Phathom Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.21-$16.26 |
Market Cap | $1B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $147.1M |
Revenue Growth (YoY) | 202.7% |
Gross Profit (12 Mos) | $128.4M |
Diluted EPS | -$3.76 |
News
See moreYahoo Finance • 18 days ago
Surprising Analyst 12-Month Target For ITOT
Yahoo Finance • last month
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease
About
CEO | Mr. Steven L. Basta M.B.A. |
Address | 100 Campus Drive, Florham Park, NJ, United States, 07932 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 427 |
